Inhibition of the MUC1-C Oncoprotein Is Synergistic With Cytotoxic Agents in the Treatment of Breast Cancer Cells

Cancer Biology and Therapy - United States
doi 10.4161/cbt.22634
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Targeting Cysteine-Mediated Dimerization of the MUC1-C Oncoprotein in Human Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2011English

Targeting of the MUC1-C Oncoprotein in Colitis-Associated Colorectal Cancer

2014English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Malonyl-CoA Decarboxylase Inhibition Is Selectively Cytotoxic to Human Breast Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

The MUC1-C Oncoprotein as a Target in Hematologic Malignancies

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2019English

Muc1-C Integrates Chromatin Remodeling and Parp1 Activity in the Dna Damage Response of Triple-Negative Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2019English

C-Myc Is a Major Mediator of the Synergistic Growth Inhibitory Effects of Retinoic Acid and Interferon in Breast Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

MUC1 Oncoprotein Blocks Nuclear Targeting of C-Abl in the Apoptotic Response to DNA Damage

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy